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A Novel Role for 3-O-Sulfated Heparan Sulfate
in Herpes Simplex Virus 1 Entry
differentiation, and homeostasis. HS and other glycos-
aminoglycans are unbranched polymers covalently
attached to the protein cores of proteoglycans, which
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the case of herpes simplex virus types 1 and 2 (HSV-1,University of Pennsylvania
HSV-2), which are human herpesviruses of the neuro-Philadelphia, Pennsylvania 19104
tropic alphaherpesvirus subfamily, the virus binds to
cells through interactions of envelope glycoproteins gB
and/or gC with cell surface HS (reviewed by Spear,
Summary 1993). Following this binding, a third viral glycoprotein,
gD, interacts with one of multiple specific receptors,
Herpes simplex virus type 1 (HSV-1) binds to cells resulting in viral entry by fusion of the virion envelope
through interactions of viral glycoproteins gB and gC with a cell membrane. This fusion reaction requires the
with heparan sulfate chains on cell surface proteogly- concerted action of three additional viral glycoproteins,
cans. This binding is not sufficient for viral entry, which gB, gH, and gL (reviewed by Spear, 1993), and appears
requires fusion between the viral envelope and cell to be triggered by the binding of gD to its cognate re-
membrane. Here, we show that heparan sulfate modi- ceptors.
fied by a subset of the multiple D-glucosaminyl 3-O- The human gD receptors identified to date include a
sulfotransferase isoforms provides sites for the bind- member of the TNF receptor family, designated HVEM
ing of a third viral glycoprotein, gD, and for initiation (Montgomery et al., 1996; Whitbeck et al., 1997) or her-
of HSV-1 entry. We conclude that susceptibility of cells pesvirus entry protein A (HveA), and officially named
to HSV-1 entry depends on (1) presence of heparan TNFRSF14, and two members of the immunoglobulin
sulfate chains to which virus can bind and (2) 3-O- superfamily (Geraghty et al., 1998; Krummenacher et al.,
1998; Warner et al., 1998). The latter two proteins aresulfation of specific glucosamine residues in heparan
related to the poliovirus receptor (CD155) (Mendelsohnsulfate to generate gD-binding sites or the expression
et al., 1989), were originally designated poliovirus recep-of other previously identified gD-binding receptors.
tor±related proteins 1 (Lopez et al., 1995) and 2 (EberleÂ
et al., 1995) and more recently named HveC (GeraghtyIntroduction
et al., 1998) and HveB (Warner et al., 1998) or nectin 1
and nectin 2 (Takahashi et al., 1999), respectively. BothHeparan sulfate (HS) is widely expressed in animal and
HveA and HveC serve as gD-binding entry receptorshuman tissues and has diverse roles in development,
for wild-type HSV-1 and HSV-2 strains, whereas HveB
serves as an entry receptor for only a subset of HSV
strains (Montgomery et al., 1996; Geraghty et al., 1998;8 To whom correspondence should be addressed (e-mail: p-spear@
Warner et al., 1998).nwu.edu [P. G. S.] and rdrrosen@mit.edu [R. D. R.]).
9 These authors contributed equally to this work. Here, we report that a different kind of gD receptor can
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be generated by the action of specific D-glucosaminyl
3-O-sulfotransferases (3-OSTs). Members of the family
of 3-OSTs are responsible for the addition of sulfate
groups at the 3-OH position of glucosamine in HS. These
enzymes are present as several isoforms expressed
from different genes at different levels in various tissues
and cells (Shworak et al., 1999). The 3-OSTs act to mod-
ify HS late in its biosynthesis (reviewed by Lindahl et
al., 1998), and each isoform recognizes as substrate
glucosamine residues in regions of the HS chain having
specific, but different, prior modifications, including epi-
merization and sulfation at other positions (Liu et al.,
1999b). Thus, different 3-OSTs generate different poten-
tial protein-binding sites in HS. Recently the 3-OST-1
isoform, but not other isoforms (3-OST-2, 3-OST-3A, and
Figure 1. Amino Acid Sequence of m3-OST-3B in Comparison with3-OST-3B), was shown to generate antithrombin-binding Those of h3-OST-3B and the Sulfotransferase Domain of h3-OST-3A
sites in HS (Liu et al., 1996, 1999b; Shworak et al., 1997).
Dots in the latter two sequences indicate identity with the m3-OST-
In this study, cells that are resistant to HSV-1 entry 3B (m/3B) sequence. Single-underlined residues of m3-OST-3B in-
were used in expression cloning experiments to identify clude the predicted membrane-spanning region, and the double-
underlined residues indicate the potential sites for addition ofmouse cDNAs capable of conferring susceptibility to
N-linked glycans. The filled triangle marks the beginning of theHSV-1 entry. The plasmid isolated in this screen en-
conserved sulfotransferase domain. The position in this conservedcodes a mouse version of 3-OST-3B. We show here that
domain of the amino acid substitution in h3-OST-3A (K162A) thatboth mouse and human forms of 3-OST-3B and a human results in loss of enzymatic activity is indicated by the shading. Within
form of 3-OST-3A modified the HS of HSV-1-resistant the sulfotransferase domain, m3-OST-3B is 91% identical to both
cells as predicted and made the cells susceptible to human 3-OST-3s; the remaining N-terminal portion of m3-OST-3B
is 81% identical to that of h3-OST-3B (h/3B) and unrelated toHSV-1 infection. Evidence is presented that the enzyme-
h3-OST-3A (h/3A).modified HS rather than the enzymes themselves served
as gD-binding receptors to permit HSV-1 entry. Thus,
gD-binding receptors needed for HSV-1 entry into cells
m3-OST-3B were able to convert at least two types ofinclude 3-OST-3-modified HS or the previously identi-
cells (CHO and mouse melanoma cells) from resistancefied protein receptors.
to susceptibility to several strains of HSV-1 (representa-
tive data shown in experiments described below).Results
Evidence that m3-OST-3B has the predicted enzy-
matic activity is presented in Figure 2. COS-7 cells wereA Murine Mediator of HSV-1 Entry Has
transfected with a plasmid expressing m3-OST-3B or the3-OST-3 Activity
empty vector, and extracts from the cells were incu-Wild-type Chinese hamster ovary (CHO) cells are resis-
bated with HS prepared from CHO cells and the sulfatetant to HSV-1 entry (Shieh et al., 1992). Screening of an
donor [35S]adenosine 39-phosphate 59-phosphosulfateembryonic mouse cDNA library for expression of pro-
([35S]PAPS). The labeled HS was then degraded for anal-teins capable of rendering CHO cells susceptible to
ysis as shown in Figure 2. Two 3-O-sulfated disaccha-HSV-1 entry resulted in isolation of pDS43. This plasmid
rides characteristic of products generated by h3-OST-3Bhas an insert of 1675 base pairs with one major open
and h3-OST-3A (Liu et al., 1999b) were detected in thereading frame encoding the protein whose sequence is
reaction mixture containing m3-OST-3B (Figure 2B) butgiven in Figure 1. A search of the databases revealed that
not in the control reaction (Figure 2A).this protein is closely related to the previously described
human protein encoding 3-OST-3B (h3-OST-3B) (Shworak
et al., 1999). We have named the mouse protein m3- Enzymatically Active Mouse and Human 3-OST-3,
but Not 3-OST-1, Are Mediators of HSV-1 EntryOST-3B because of its similarity in sequence to h3-
OST-3B (Figure 1) and because of its enzymatic activity Wild-type CHO cells were transfected with plasmids ex-
pressing various 3-OSTs and then exposed to a recom-described below.
Both m3-OST-3B and h3-OST-3B are predicted to be binant HSV-1 strain that expresses b-galactosidase
upon entry into cells [HSV-1(KOS)gL86]. All three en-type II membrane glycoproteins of 390 amino acids with
features described previously (Shworak et al., 1999) and zymes that catalyze the sulfation reactions described in
Figure 2 (m3-OST-3B, h3-OST-3B, and h3-OST-3A) ren-indicated in Figure 1. Evidence that m3-OST-3B is ori-
ented in membranes as a type II membrane protein was dered CHO cells susceptible to HSV-1 entry, whereas
m3-OST-1, shown in parallel experiments to be ex-obtained by expressing a tagged version of the protein
(Myc epitope fused to the C terminus) in CHO cells and pressed as active enzyme (data not shown), had little
if any viral entry activity (Figure 3). The 3-O-sulfatedshowing that anti-Myc antibodies could bind to live un-
fixed cells (data not shown). This result also indicates disaccharides characteristic of HS modified by human
or mouse 3-OST-1 are -GlcA-GlcNS66S3S- (Shworakthat m3-OST-3B can be transported to the cell surface
even though its principal intracellular location is likely to et al., 1997), whereas those characteristic of 3-OST-3
modifications are -IdoA2S-GlcNH266S3S- (Liu et al.,be the terminal Golgi compartment(s) where HS sulfation
occurs. Both the Myc-tagged and untagged versions of 1999b).
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Figure 2. Enzymatic Activity of m3-OST-3B and Inactivation of h3-OST-3A Activity by K162A Amino Acid Substitution
Cell extracts from COS-7 cells transfected with the empty plasmid vector pcDNA3 (A) or with plasmids expressing m3-OST-3B (B) or mutated
h3-OST-3A(K162A) (C) were incubated with HS prepared from CHO cells and [35S]PAPS, and then 35S-labeled degradation products of the HS
were generated by nitrous acid treatment and reduction with sodium borohydride, as outlined in (D), and analyzed by HPLC (A±C). This method
of degradation results in conversion of glucosamine to anhydromannitol. The arrows in (A) indicate the elution positions of disaccharide
standards, where 1 is IdoA2S-aManol3S, 2 is GlcA-aManol3S6S, 3 is IdoA2S-aManol6S, and 4 is IdoA2S-aManol3S6S. IdoA2S-[35S]aManol3S
and IdoA2S-[35S]aManol3S6S are the characteristic disaccharides resulting from digestion of h3-OST-3B- or h3-OST-3A-modified HS (Liu et
al., 1999b). (D) illustrates the composition of HS, presence of sulfated and unsulfated domains in HS, potential cleavage sites for heparinases
I and III, and the biosynthetic steps altered in CHO cell mutants pgsA-745 (defective in xylosyltransferase and all GAG assembly), pgsD-677
(defective only in HS formation due to loss of HS copolymerase activity), pgsE-606 (z50% defective in GlcNAc N-deacetylation and N-sulfation
due to mutation of one isozyme responsible for this activity), and pgsF-17 (defective in 2-O-sulfotransferase).
A mutated form of h3-OST-3A, in which the Lys at Krummenacher et al., 1998), or with the empty vec-
tor, pcDNA3. The cells were then exposed to HSV-position 162 was changed to Ala, was shown by Western
blot analysis to be expressed at a level comparable to 1(KOS)gL86 for quantitation of viral entry. Figure 4B
shows that the various cell lines transfected with thethat of wild-type enzyme (data not shown) but to have
little or no enzymatic activity (Figure 2C) and no viral m3-OST-3B-expressing plasmid produced equivalent
amounts of the protein. Figure 4A shows that mutationsentry activity (Figure 3C). This particular amino acid sub-
stitution in a highly conserved region of the sulfotrans- affecting HS biosynthesis had different consequences
for HSV-1 entry, depending on whether the cells ex-ferases (Figure 1) was shown previously to dramatically
reduce enzymatic activity of a flavonol 3-sulfotransfer- pressed m3-OST-3B or HveC, and also that all of the cell
lines transfected with control plasmid were resistant toase with minimal effect on PAPS binding (Marsolais and
Varin, 1995). Moreover, mutagenic and structural studies HSV-1 entry. The first point to be made is that expression
of m3-OST-3B permitted HSV-1 entry only in wild-typedemonstrated that the conserved Lys has a comparable
critical role in catalysis by a heparan N-sulfotransferase CHO cells and in pgs606 mutant cells. HS produced by
this mutant has the modifications characteristic of wild-(Sueyoshi et al., 1998; Kakuta et al., 1999).
type cells, but at a reduced level, because the N sulfation
that is prerequisite for other modifications occurs atFunction of m3-OST-3B as an HSV-1 Entry Mediator
Depends on HS Production and on 2-O-Sulfation about 50% of wild-type level (Bame and Esko, 1989;
Aikawa and Esko, 1999). The other cell lines either failof HS
Given that HSV-1 entry activity correlated with 3-OST-3 to produce HS (pgsA-745 cells produce no glycosami-
noglycans [Esko et al., 1985] and pgsD-677 cells pro-enzymatic activity, we determined whether entry activity
depended on presence of cell surface HS that could be duce only chondroitin sulfate [Lidholt et al., 1992]) or
fail to modify the hexuronic acid residues of HS by themodified by 3-OST-3. Wild-type CHO cells and several
mutant cell lines defective for different steps in assembly addition of 2-O-sulfate groups (pgsF-17) (Bai and Esko,
1996). Because the substrate for 3-OST-3s is a glucos-and modification of HS (Figure 2D) were transfected with
plasmids expressing the Myc-tagged version of m3- amine residue adjacent to 2-O-sulfated IdoA, incubation
of HS from pgsF-17 cells with purified 3-OST-3A shouldOST-3B or HveC, a human protein that can serve as a
gD-binding entry receptor for HSV (Geraghty et al., 1998; not yield the characteristic disaccharides resulting from
Cell
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Figure 4. HSV-1 Entry Activity of m3-OST-3B Depends on Presence
of Cell Surface HS and on 2-O-Sulfation of the HS
(A) Wild-type CHO cells or CHO cell mutants (Figure 2D) were trans-
fected with plasmids expressing HveC or m3-OST-3B (Myc-tagged)
or with the empty vector pcDNA3. The cells were then exposed toFigure 3. Entry of HSV-1 into CHO Cells Mediated by Murine or
HSV-1(KOS)gL86 at various input doses and b-galactosidase wasHuman 3-OST-3B or 3-OST-3A
quantitated after 6 hr, as described in Figure 3, as a measure of
CHO cells transfected with plasmids expressing the murine or hu-
viral entry. The results shown (means of triplicate determinations
man forms of the enzymes indicated or the enzymatically inactive
plus standard deviation) are for 7.5 3 105 pfu/well, an amount of virus
mutant h3-OST-3A(K162A), or with the empty vector pcDNA3, were within the linear range of the dose response curve for all samples.
exposed to various concentrations of HSV-1(KOS)gL86, which ex-
(B) Extracts were prepared from replicate cultures of the transfected
presses b-galactosidase from an insert in the viral genome immedi-
cells described in (A) for detection of m3-OST-3B (Myc-tagged) ex-ately upon entry into cells. b-galactosidase activity was quantitated
pression by Western blot, using an anti-Myc mAb.
as a measure of viral entry at 6 hr after the addition of virus. The
values shown represent the amount of reaction product detected
spectrophotometrically (OD410). First, a mutant of HSV-1(KOS) that has a single amino
acid substitution at position 27 in gD (Dean et al., 1994)
was unable to infect cells expressing m3-OST-3B (data3-OST-3 activity, as was confirmed experimentally (Ta-
not shown). Other phenotypes caused by this mutationble 1). Second, in contrast to the results obtained with
(Rid1 mutation) include loss of ability to infect HveA-m3-OST-3B, expression of HveC rendered all the cell
expressing cells (Montgomery et al., 1996) and acquiredlines susceptible to HSV-1 entry (Figure 4A), indicating
ability to infect cells expressing HveB (Warner et al.,that presence of HS was not required for HveC-depen-
1998).dent entry. The presence of HS to which HSV-1 could
Second, both membrane-bound and soluble gD com-bind via gB or gC clearly enhanced viral entry, however.
peted with virus for the receptors generated by 3-OST-3.The ability of HS to enhance the susceptibility resulting
from HveC expression depended on the overall level of
sulfation (wild-type was greater than pgsE-606 cells) Table 1. Disaccharide Compositions of 3-OST-3A-Modified HS
and on 2-O-sulfation of hexuronic residues (pgsF-17 from Wild-Type CHO Cells and 2-OST-Deficient
cells), consistent with previous studies suggesting that pgsF-17 Cells
these groups are important for HSV-1 binding to cells Source of HSa
(Herold et al., 1996; Feyzi et al., 1997). Third, we have
Wild Type pgsF-17 Wild Type:reproducibly found in multiple experiments that HveC
Disaccharides (pmol) (pmol) pgsF-17can confer greater susceptibility to HSV-1 entry than
IdoA2S-[35S]aManol3Sb 6.7 0.3 22:1does m3-OST-3B. In the case of HveC, new gD-binding
IdoA2S-[3-35S]aManol3S6Sb 5.1 0.2 26:1receptors are overexpressed from the transfected plas-
IdoA-[3-35S]aManol3S6S 0.2 1.4 1:7mid, whereas, in the case of m3-OST-3B, the enzyme GlcA-[3-35S]aManol3S6S Not detected 0.2 Ð
may modify endogenous molecules to generate recep-
a[35S]HS was prepared by incubating unlabeled HS (1 mg) from wild-tors for virus. If so, the levels of endogenous receptor
type CHO cells and pgsF-17 cells with purified 3-OST-3A (60 ng)would govern the degree of susceptibility to infection
in the presence of [35S]PAPS (20 3 106 cpm, 10 mM). The [35S]HS
that could be attained. was degraded with nitrous acid at pH 1.5 followed by a reduction
with sodium borohydride. The [35S]disaccharides were isolated by
HSV-1 Entry Mediated by 3-OST-3 Depends Biogel P-2 and analyzed on reverse phase ion pairing HPLC. The
identities of the [35S]disaccharides were determined by coelutionon Modified HS as a gD Receptor
with [3H]disaccharide standards.Several lines of evidence demonstrated that HSV-1 entry
bThe characteristic disaccharides resulting from 3-OST-3A modifica-mediated by mouse or human 3-OST-3 is dependent on
tion and degradation.
gD and on the generation of gD-binding sites in HS.
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Table 2. The Binding of Enzyme-Modified HS to gD-1
[3H]HS Bound to gD-1 (306t) (%)b
[3H]HSa Wild Type pgsF-17
Unmodified HS 1.7 6 0.9 (n 5 5) 0.1 6 0.1 (n 5 2)
3-OST-1-modified HSc 3.4 6 1.6 (n 52) ND
3-OST-3A-modified HSd 14.8 6 1.7 (n 5 6) 1.6 6 0.7 (n 5 2)
aMetabolically labeled [3H]HS from wild-type CHO or pgsF-17 cells
was incubated with [35S]PAPS and purified m3-OST-1 (60 ng) or h3-
OST-3A (60 ng).
bThe binding of the modified or unmodified [3H/35S]HS to gD-1(306t)
was determined by incubating mixtures with the anti-gD antiserum
R7 (or the anti-gD monoclonal antibody DL6, 5 ml) to form an immune
complex. The percentage of input HS bound to gD-1(306t) was
calculated based on the input and eluted 3H counts. Data are ex-
pressed as the mean 6 SD. ND, not determined.
cThe sulfated structure generated is -GlcA-GlcNS66S3S-.
dThe sulfated structure generated is -IdoA2S-GlcNH266S3S-.
Affinity coelectrophoresis (Lee and Lander, 1991) was
performed to estimate dissociation constants for the
gD±HS interactions. [35S]HS was purified from CHO cells,
modified by incubation with purified h3-OST-3A in vitro
and then fractionated by coimmunoprecipitation with
gD-1(306t), yielding HSgD´Act in the bound fraction and
HSgD´Inact in the unbound fraction. The fraction of labeled
HS in the bound fraction was similar to that shown inFigure 5. HSV-1 gD Competes with Virus for Receptors Generated
Table 2. The two preparations of HS were then electro-by m3-OST-3B
phoresed in an agarose gel through zones containing(A) CHO cells were transfected with a m3-OST-3B-expressing plas-
gD-1(306t) at various concentrations. The migration ofmid mixed in 1:4 ratio with a gD-1-expressing plasmid or the empty
vector pcDNA3. The transfected cells were then exposed to HSV- HSgD´Act was retarded by the presence of gD-1(306t), with
1(KOS)gL86 at the input doses indicated and viral entry quantitated the degree of retardation dependent on the gD-1(306t)
after 6 hr, as described in Figure 3. concentration (Figure 6A), whereas the migration of
(B) CHO cells transfected with a plasmid expressing m3-OST-3B HSgD´Inact was much less affected (data not shown). From
were exposed to HSV-1(KOS)gL86 (7.5 3 105 pfu/well) that had been
these data the KD for interaction of HSgD´Act with gD-preincubated with gD-1(D290±299t), a soluble form of gD-1 shown
1(306t) was calculated to be 2 mM, whereas the KD forto block the infection of cells via other gD-binding receptors (Whit-
beck et al., 1997), or with BSA, at the concentrations indicated. Viral HSgD´Inact was 43 mM or greater (Figure 6B), considering
entry was quantitated at 6 hr as described above. that the removal of HSgD´Act from the HSgD´Inact fraction was
undoubtedly not complete.
Efforts to demonstrate direct interactions betweenCoexpression of HSV-1 gD with m3-OST-3B in CHO cells
made the cells more resistant to HSV-1 entry (Figure 3-OST-3 and gD were unsuccessful. In ELISA assays no
binding of purified gD-1(306t) to purified h3-OST-3A was5A). Cellular expression of gD has been shown to inter-
fere with HSV-1 entry only when the form of gD ex- evident, whereas binding to purified HveC was readily
detected in control experiments (data not shown).pressed by the cell is capable of interacting with the gD
receptors (HveA, HveB, or HveC) available for viral entry Finally, experiments were done to determine whether
heparinases could remove from 3-OST-3-expressing(Mauri et al., 1998; Geraghty et al., unpublished data).
Also, a soluble truncated form of gD, shown previously cells the receptors that bind gD and mediate viral entry.
Wild-type CHO cells or pgsA-745 cells were transfectedto block HSV-1 entry into cells expressing HveA (Whit-
beck et al., 1997), inhibited infection of CHO cells trans- with plasmids expressing m3-OST-3B or h3-OST-3A or
with control plasmid, and the wild-type cells were laterfected with m3-OST-3B (Figure 5B).
Third, binding of gD to 3-OST-3-modified HS, but not incubated with a mixture of heparinases I and III, which
cleave HS at different sites (Figure 2D) to liberate theto the enzymes themselves, could be demonstrated. HS
extracted from wild-type CHO cells was left unmodified majority of HS chains from the cell surface, or incubated
in buffer without the heparinases. The cells were thenor sulfated by incubation in vitro with 3-OST-1 or h3-
OST-3A and tested for binding to gD in coimmunoprecip- incubated with a gD hybrid protein consisting of the
ectodomain of gD fused to the Fc of rabbit IgG (gD-itation experiments. Table 2 shows that the fraction of
input labeled HS bound to immunoprecipitated gD- 1:Fc). Figure 7A shows that expression of either 3-OST-3
caused enhanced binding of gD-1:Fc to the untreated1(306t) was enhanced almost 10-fold for HS modified
by incubation with 3-OST-3A. Modification by 3-OST-1 CHO cells (but not to the pgsA-745 cells) and that this
enhanced binding was eliminated by pretreatment ofdid not significantly enhance the binding to gD-1(306t).
The HS from pgsF-17 cells, after incubation with the wild-type cells with heparinases I/III. Figure 7B
shows that, for CHO cells expressing m3-OST-3B, treat-3-OST-3A, bound to gD-1(306t) with about the same effi-
ciency as unmodified HS from CHO cells. ment with heparinases I/III almost completely eliminated
Cell
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Figure 7. Enzymatic Removal of 3-OST-3-Modified HS from Cells
Removes gD-Binding Receptors and Renders the Cells Resistant
to HSV-1 Entry
(A) Wild-type CHO cells or pgsA-745 cells transfected with plasmids
Figure 6. Binding Constant (KD) for Interaction between h3-OST-3A- expressing m3-OST-3B or h3-OST-3A or with the empty vector
Modified HS and gD-1 as Determined by Affinity Coelectrophoresis pcDNA3 were treated with heparinase I/III (4 U/ml of each) or were
(A) Autoradiograph of the agarose gel in which [35S]HS purified by incubated with the enzyme buffer but without added enzyme. The
coprecipitation with gD-1(306t) (HSgD´Act) was electrophoresed cells were then washed and incubated with gD-1:Fc for 30 min,
through zones containing gD-1(306t) at the concentrations indi- followed by fixation and incubation with a secondary antibody and
cated. Approximately 50,000 cpm (1.3 3 10215 mol) of [35S]HSgD´Act a horseradish peroxidase detection system. The values shown
was loaded in each separation zone. (means of triplicate determinations plus standard deviations) repre-
(B) Plot of R/[gD-1]total versus R, where the retardation coefficient sent the amount of reaction product detected spectrophotometri-
R 5 (M0 2 M)/M0. M0 is the migration of free [35S]HS, and M is cally (OD370). In this experiment (samples indicated by the asterisk)
the observed migration of [35S]HS in the presence of gD-1(306t). and two others, the difference in amount of gD-1:Fc bound to 3-OST-
Assuming that [35S]HS and gD-1 form a 1:1 complex and gD-1 is in 3-expressing cells and control cells was statistically significant (Stu-
great excess, this plot should yield a straight line with a slope of dent's t test, p , 0.001).
21/KD according to the Scatchard equation. The main plot (linear (B) CHO cells transfected with plasmids expressing m3-OST-3B or
coefficient value 5 0.89) shows the results of the analysis done with HveC were treated with heparinases I/III at the concentrations indi-
[35S]HSgD´Act (A), whereas the inset (linear coefficient value 5 0.92) is cated (total units present in 1:1 mixtures) or were incubated with
for the analysis done with [35S]HSgD´Inact (HS that failed to coprecipitate the enzyme buffer but without added enzymes. The cells were then
with gD-1[306t]). exposed to HSV-1(KOS)gL86 at 7.5 3 105 pfu/well and viral entry
was quantitated 6 hr later, as described in Figure 3. Entry into the
heparinase I/III-treated cells is presented as a percentage of the
entry into mock-treated cells.
susceptibility to HSV-1 entry, whereas for cells express-
ing HveC, this treatment reduced susceptibility to HSV-1
infection by only 50%.
presence of the appropriate HS substrate and on enzy-
matic activity, that gD receptors are generated by theDiscussion
action of these enzymes, and that these gD receptors
can be removed from cells by the action of heparinases.The surprising finding is that specific sites in HS can
serve as gD-binding receptors for HSV-1 entry into cells. The previously identified gD-binding receptors for
wild-type HSV-1 are HveA (TNFRSF14) and HveC (nectinThese sites are of unknown size but must include one
of the disaccharides, -IdoA2S-GlcNH23S6S- or -IdoA2S- 1 or Prr1), both cell surface proteins (Montgomery et al.,
1996; Geraghty et al., 1998). The apparent diversity ofGlcNH23S-. This conclusion is based on evidence that
3-OST-3s capable of introducing the final modification functional gD receptors, which include proteins from
two different families and specific sites in HS, is aston-characteristic of these disaccharides can convert resis-
tant cells to susceptibility to HSV-1 entry, that ability ishing. In all three cases, the dissociation constants for
interactions with soluble gD are in the range of 2±3 3of the 3-OST-3s to confer susceptibility depends on
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1026 M (Willis et al., 1998; Krummenacher et al., 1999; range, suggesting that other isoforms of the 3-OSTs
this study). It should be noted that gD does not normally should be tested for their ability to mediate entry of
mediate the binding of virus to cells. This role is taken HSV-1 and HSV-2. Finally, the fact that cells expressing
by gB and/or gC (Herold et al., 1991, 1994). The binding 3-OST-3 are more susceptible to HSV-1 than to HSV-2
of virus to cell surface HS clearly does not require the provides a basis for investigating differential susceptibil-
same modifications as are introduced by 3-OST-3s to ity of human cell types to HSV-1 and HSV-2 and potential
generate gD binding activity, because unmodified HS contribution of this differential susceptibility to patterns
expressed by CHO cells is fully functional for HSV-1 of disease.
binding but not for entry (Shieh et al., 1992). It seems
Experimental Procedureslikely that the role of gD is, through its interactions with
any one of several specific cell surface molecules, to
Cells and Virusesactivate the fusogenic activity of other viral glycopro-
Wild-type CHO cells and the mutant cell lines pgsA-745 (Esko etteins, gB and/or gH±gL. Probably, gD is not itself a
al., 1985), pgsD-677 (Lidholt et al., 1992), pgsE-606 (Bame and Esko,
fusogen, based on findings with other alphaherpesvi- 1989; Aikawa and Esko, 1999), and pgsF-17 (Bai and Esko, 1996)
ruses that absence of gD can be compensated by sec- were grown in Ham's F12 medium supplemented with 10% fetal
ond-site mutations resulting in recovery of some viral bovine serum. Wild-type virus strains used were HSV-1(KOS), HSV-
1(Patton), HSV-1(F), and HSV-2(333). Mutant strains includedinfectivity (Schmidt et al., 1997; Schroder et al., 1997).
HSV-1(KOS)Rid1 and Rid2 (Dean et al., 1994). Recombinant virusesThe results presented here raise the possibility that
carrying the lacZ gene of E. coli and capable of expressing b-galac-HSV-1 entry into cells could be mediated entirely by HS,
tosidase as a reporter of entry included HSV-1(KOS)gL86 (Montgom-
provided the appropriate sites for virus binding and gD ery et al., 1996), HSV-1(KOS)tk12, and HSV-1(KOS)Rid1-tk12 (War-
binding were present in the HS. Alternatively, HveA or ner et al., 1998).
HveC could serve as the operative gD-binding receptor.
Antibodies and Purified Recombinant ProteinsHveA (Montgomery et al., 1996), HveC (Lopez et al.,
Antibodies used included rabbit antiserum R7 specific for HSV gD1995; Geraghty et al., 1998), and the 3-OST-3s (Shworak
(Isola et al., 1989), the anti-gD mAb DL6 (Isola et al., 1989), and anet al., 1999) are all expressed in a variety of human
anti-Myc mAb (cat. no. R950-25, Invitrogen). Purified recombinanttissues and cell types, making it difficult to predict which
proteins included m3-OST-1 secreted from L cells (Liu et al., 1996),
is the operative gD receptor for any given cell type in a secreted N-truncated form of h3-OST-3A (Liu et al., 1999a), and
vivo. Also, we cannot rule out the possibility that addi- two secreted C-truncated forms of gD-1, designated gD-1(306t) and
tional unidentified cell surface receptors participate in gD-1(D290±299t) (Nicola et al., 1996). The latter three proteins were
produced in insect cells from baculovirus vectors and purified asHSV-1 entry. If these putative additional receptors exist,
described in the references cited. The hybrid protein gD-1:Fc wasit seems unlikely that they mediate the binding of virus
produced by CHO cells transfected with plasmid pBG64 and purifiedto cells, but they could interact with viral ligands made
from the medium (Ham's F12 supplemented with 3% fetal bovine
accessible after interaction of the virus with HS, 3-O- serum depleted of IgG) by protein G±Sepharose chromatography.
sulfated HS, or one of the other gD-binding receptors.
Wild-type strains of HSV-1 and HSV-2 seem to be Screening Assay for Plasmids Encoding HSV-1 Entry Proteins
A 15.5 days gestation mouse embryonic cDNA expression libraryequivalent in usage of HveA or HveC for entry, but they
(GIBCO-BRL) was screened for plasmids capable of rendering trans-differ in usage of the receptors generated by 3-OST-3.
fected CHO cells susceptible to HSV-1 entry, essentially as de-Mouse melanoma cells expressing 3-OST-3 in the ab-
scribed previously (Montgomery et al., 1996). A single plasmid, des-sence of HveA or HveC are significantly more suscepti-
ignated pDS43, was obtained. Nucleotide sequence of the insert
ble to HSV-1 strains than to HSV-2 (D. S. and P. G. S., was determined by the University of Chicago Cancer Research Cen-
unpublished results), suggesting that expression of ter Sequencing Facility, using a UBI Prism 377 DNA sequencer. The
these enzymes could predispose human cells to HSV-1 sequence of the insert was deposited in GenBank (Accession No.
AF168992).infection. While the clinical manifestations of disease
caused by HSV-1 and HSV-2 can be indistinguishable,
Plasmidsthere are differences in epidemiology and pathogenesis
Plasmid pDS43/myc-His was generated by in-frame fusion of the Cof disease caused by the two serotypes (Lafferty et al.,
terminus of the m3-OST-3B open reading frame, through conversion1987; Corey and Spear, 1988). HSV-1 is the usual cause of the stop codon to a BamHI site, with the Myc-His tag from the
of adult sporadic encephalitis, keratitis, and oral muco- plasmid pcDNA3.1/myc-His (Invitrogen). Plasmid pBG64 has the
cutaneous lesions, whereas HSV-2 is more likely to ectodomain of HSV-1(KOS) gD (amino acids 1±343) fused in frame
to the Fc region of a rabbit IgG heavy chain and cloned into pcDNA3.cause genital lesions, meningitis, and neonatal infec-
Plasmids described elsewhere include those expressing m3-OST-1tions. A factor contributing to these differences could be
(Shworak et al., 1997), h3-OST-3A, and h3-OST-3B (Liu et al., 1999b),preference for different receptors and perhaps different
pBG38 expressing HveC (Geraghty et al., 1998), and pRE4 express-cell types.
ing HSV-1 gD (Cohen et al., 1988).
Our results demonstrate that human and mouse
3-OST-3s can modify HS to provide sites for the binding Enzymatic Modification of HS and Analysis of Products
of HSV-1 gD and that presence of these sites is associ- Purified enzymes (m3-OST-1 or h3-OST-3A) or extracts of COS-7
ated with susceptibility of the cells to viral entry in the cells (Shworak et al., 1997) expressing various forms of 3-OST-3
were incubated with HS prepared from wild-type CHO cells or pgsF-absence of any known protein gD-binding receptors.
17 cells and [35S]PAPS. The reaction conditions, detailed in the text,Given that these enzymes are widely expressed in hu-
ensure the modification of all potential 3-O sulfation sites recognizedman tissues (Shworak et al., 1999), and also in mouse
by each enzyme. In some cases the enzyme-modified or unmodified
tissues (D. S. and P. G. S., unpublished results), the HS was then incubated with nitrous acid at pH 1.5 and 08C for 30
ability of 3-OST-3 to mediate HSV-1 entry may partially min and reduced with sodium borohydride (0.05 M) under alkaline
explain the very broad host range of HSV-1 with respect conditions at 508C for 30 min (Liu et al., 1999b). The nitrous acid±
degraded HS products were resolved by chromatography on BioGelto cell type and species. HSV-2 also has a broad host
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P-2. The disaccharides (about 60% of total loaded 35S counts) were as described above. The molecules that failed to coprecipitate were
designated [35S]HSgD´Inact, although this fraction probably containedsubfractionated on reversed-phase ion pairing HPLC with appro-
priate disaccharide standards (Liu et al., 1999a). some gD-1-binding material. Purified gD-1(306t) was cast in low
melting point 1% agarose gel (GIBCO) in a buffer containing 125
mM sodium acetate, 50 mM 3-(N-morpholino)-2-hydroxypropane-Entry Assays
sulfonic acid, and 0.5% 3-[(3-cholamidopropyl)dimethylammonio]-Entry assays were based on quantitation of b-galactosidase ex-
1-propane-sulfonate (pH 7.0) at nine different concentrations forpressed from the viral genome or by CHO-IEb8 cells in which
[35S]HSgD´Act, ranging from 0 to 11 mM, and at four different concentra-b-galactosidase expression is inducible by HSV infection (Montgom-
tions for [35S]HSgD´Inact, ranging from 0 to 83 mM, in each separationery et al., 1996). Cells were transiently transfected in six-well dishes,
zone. Approximately 50,000 cpm of [35S]HSgD´Act or [35S]HSgD´Inact wasusing Lipofectamine (GIBCO-BRL) with plasmids expressing one of
loaded in each separation zone and electrophoresis was performedthe entry mediators or control plasmid, pcDNA3, at 1.5 to 2.0 mg
at 400 mA for 2.5 hr in a cold room with circulated cold water. Theper well in 1 ml. At 24 hr after transfection, the cells were replated
gels were dried and analyzed on a Beta-scope 603 (Betagen) toin 96-well tissue culture dishes (2±4 3 104 cells/well) at least 16 hr
determine the migration of [35S]HS. The [35S] intensity was plottedprior to infection. Cells were washed and exposed to virus in 50 ml
against the migration distance through the separation zone to defineof phosphate-buffered saline (PBS) containing glucose and 1% calf
the distance migrated in the presence or absence of gD-1(306t).serum (PBS-G-CS) for 6 hr at 378C before solubilization in 100 ml of
PBS containing 0.5% NP-40 and the b-galactosidase substrate,
o-nitro-phenyl b-D-galactopyranoside (ONPG, 3 mg/ml). The enzy- Detection of gD-1 Receptors on Cells
matic activity was monitored by spectrometry at several time points CHO cells and pgsA-745 cells were transfected with pDS43 or
after the addition of ONPG to define the interval over which the pcDNA3 and plated in 96-well plates as described above. Some
generation of product was linear with time (Dynatech ELISA reader cultures were treated with heparinases as described below prior to
or a Spectromax 250). Results are presented as the means of tripli- the assay. After washing the cells and blocking with PBS containing
cate or quadruplicate determinations. Assays for inhibition of infec- 3% BSA for 30 min, the cells were incubated with purified gD-1:Fc
tion by soluble gD were similar, except that dilutions of virus were (1 mg/ml) in 1% BSA-PBS for 45 min at room temperature. The
mixed with gD-1(D290±299t) or BSA and incubated for 30 min at cells were then washed and fixed with 2% formaldehyde and 0.2%
378C prior to addition of the mixtures (50 ml/well) to washed cell gluteraldehyde in PBS. Cell-bound gD-1:Fc was detected by se-
monolayers. quential incubations with biotin-conjugated goat anti-rabbit IgG an-
tibody (Sigma), Amdex streptavidin-horseradish peroxidase (Amer-
gD Interference Assay sham Pharmacia Biotech, Inc.), and the peroxidase substrate
Wild-type CHO cells were cotransfected, using Lipofectamine 3,39,5,59-tetramethyl benzidine (Sigma) in 50 mM phosphate-citrate
(GIBCO-BRL), with m3-OST-3B expression plasmid (pDS43/myc- buffer. Product was quantitated by use of a Spectromax 250 ELISA
His) and gD expression plasmid (pRE4 for HSV-1 wild-type gD) or reader to measure OD370.
control plasmid (pcDNA3), in 1:4 (m3-OST-3B :gD or control) ratio,
in 6-well dishes (2 mg of plasmid DNA total/well). After 24 hr the Heparinase Treatment
transfected cells were replated in 96 well plates and, 24 hr later, were Heparinase I (heparin lyase I; heparinase; EC 4.2.2.8) and heparinase
exposed to various doses of b-galactosidase-expressing HSV-1. Six III (heparitin sulfate lyase III; heparitinase, EC 4.2.2.8) were obtained
hours later, viral entry was quantitated as described above. from Sigma. Transfected cells plated in 96-well dishes were washed
twice with PBS lacking magnesium and calcium ions, overlayed with
Western Blot several dilutions of heparinase I and heparinase III or PBS alone,
For Western blot analyses, cells transfected with pDS43/mycHis or and incubated at 308C for 2 hr. The cells were then washed with
control plasmid pcDNA3 were lysed in sample buffer for SDS-PAGE. PBS and used for viral entry assays or for quantitation of gD-1:Fc
After electrophoresis, the separated proteins were transferred to a binding to the cells.
nitrocellulose membrane that was blocked with 5% skim milk (w/v)
in PBS and 0.05% (w/v) Tween 20 (PBS-T) for 1 hr at room tempera-
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